LENZ Therapeutics Inc (LENZ) is a Healthcare · Biotechnology company listed on NASDAQ. Price $4.07 (-1.45%), Market cap $0.23B, 52-week low–high $7.29 ~ $49.05.
LENZ Therapeutics, Inc. operates as a commercial pharmaceutical company that focuses on the development and commercialization of therapies to improve vision in the United States. Its product candidates include VIZZ and LNZ101 for the treatment of presbyopia in adults. LENZ Therapeutics, Inc. was formerly known as Presbyopia Therapies, Inc. and changed its name to LENZ Therapeutics, Inc. in June 2021. The company was founded in 2013 and is headquartered in Solana Beach, California.
Financial statements, price targets, institutional (13F) holdings and related news for LENZ Therapeutics Inc are updated in real time on BlackAll Trade.
LENZ Therapeutics Inc trades at $4.07 (-1.45%). Real-time quotes and charts are available on BlackAll Trade.
LENZ Therapeutics Inc has a market cap of about $0.23B.
LENZ Therapeutics, Inc. operates as a commercial pharmaceutical company that focuses on the development and commercialization of therapies to improve vision in the United States. Its product candidate